The study examined the system’s efficacy as a trans-oral treatment for gastroesophageal reflux disease. The study found:
• 85 percent of GERD patients reduced proton pump inhibitor use by 50 percent or more
• Of these patients, 65 percent were able to eliminate medication use after six months
• 73 percent of patients reported improved quality of life scores of 50 percent or more
More Articles on Gastroenterology:
Adenoma Detection Rate: Lowering Colorectal Cancer Risk
12 Gastroenterologist Moves & Honors
Defining Leadership in the GI Field: 2 Gastroenterologists Discuss Their Strategies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.